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 ABSTRACT 
 
 
 
 Phosphorylase kinase (PhK), a key regulator of glycogenolysis, is critical 
for maintaining blood glucose levels thus providing energy to sustain muscle 
contraction.  A deficiency of PhK in skeletal muscle is the cause of one type of 
glycogen storage disease (GSD) in humans.  This study investigates the 
physiological and genetic adaptations that occur in a mouse model of GSD, I/LnJ 
mice, in response to voluntary exercise.  Juvenile (6-8 weeks old) and adult (12-
14 weeks old) I/LnJ and wild-type C57/Bl6 mice exercised voluntarily for 1, 2 or 5 
weeks.  Exercise data was calculated as mean daily running time, daily running 
distance, total running time, total running distance, and average speed.  After five 
weeks, adult and juvenile I/LnJ mice were running 45-70% of the daily distance 
of age-matched, wild-type mice.  A training effect was observed in wild-type mice 
during the five week exercise period, but no significant difference was observed 
in heart/body weight ratios in exercised mice compared to non-exercised 
controls.  Expression levels of glucose transporter 4 (GLUT4), pyruvate 
dehydrogenase (PDHA1), and phosphofructokinase (PFKM) as a result of 
exercise were determined by quantitative RT-PCR in both I/LnJ and  
ii 
 C57/Bl6 mice.  No significant differences in expression levels were found 
between mouse strains.  Our long term goal is to gain insights into the I/LnJ 
strain’s PhK deficiency in order to better understand human GSDs. 
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 CHAPTER 1 
 
INTRODUCTION 
 
 One of the common sources of energy in the body is the simple sugar 
glucose, which is acquired from dietary carbohydrates or can be synthesized in 
the body from various other substrates (Figure 1.1).  To be used as energy, 
glucose is transported to cells through the blood stream where it is broken down 
via a process called glycolysis to produce pyruvic acid.  The irreversible and 
path-determining step in glycolysis is the conversion of fructose 6-phosphate, a 
derivative of glucose, into fructose 1,6-bisphosphate, catalyzed by 
phosphofructokinase (1).  The resulting pyruvic acid is converted by pyruvate 
dehydrogenase into acetyl-CoA, which is sent into the citric acid cycle to produce 
a functional energy molecule, adenosine triphosphate (ATP) (1).  ATP is referred 
to as the energy currency of the cell and is used to drive countless cellular 
processes including muscle contraction.   
 For storage purposes, glucose can be converted into a polymeric form, 
glycogen, which is mostly found in skeletal muscle tissue and liver tissue, 
although other cells can synthesize it (2).  When needed, glycogen is broken 
down through the process of glycogenolysis into glucose molecules in order to
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Figure 1.1. Metabolism of dietary carbohydrates. As carbohydrates are digested and converted into 
glucose-6-phosphate, their fate is determined by the needs of the body and complex signaling 
mechanisms. 
 sustain muscle contraction and to maintain blood glucose levels (3).  Two key 
hormones involved in the regulation of glycogenolysis are epinephrine, aka, 
adrenaline, which acts on muscle and liver cells, and glucagon, which mainly 
affects liver cells (4).  Hormonal regulation is crucial, for instance, when glucose 
levels in the blood are too low; the pancreas is stimulated to secrete glucagon 
which binds to specific receptors on the liver to initiate glycogenolysis (5).  
Several enzymes are involved in the reaction mechanism of glycogenolysis 
(Figure 1.2).  The rate limiting step of the reaction is catalyzed by glycogen 
phosphorylase, which severs the glucose molecules via a phosphorylation 
mechanism.  Glycogen phosphorylase is likewise activated via phosphorylation 
by phosphorylase kinase (PhK) (6).   
 PhK is a hexadecamer made up of four sets of four different subunits, α, 
β, γ, and δ.  The α- and β- subunits are thought to be mainly regulatory, whereas 
the γ subunit is the catalytic subunit of the enzyme (7).  The activity of the 
enzyme is dependent upon Ca2+ as its δ subunit is an intrinsic calmodulin 
molecule.  In skeletal muscle cells, contraction is stimulated by an influx of Ca2+ 
into the cytoplasm which also stimulates PhK activity.  Therefore, muscle 
contraction and glycogenolysis are linked (6).  Muscle contraction is sustained 
through Ca2+-stimulated glycogenolysis as more glucose becomes available for 
ATP production. 
  In conjunction with internal glycogen stores, the peripheral blood is also a 
large source of glucose for skeletal muscle.  Uptake of glucose from the blood
3 
 4 
Figure 1.2.  Hormonal control of glycogenolysis. Source: 
Puri, Dinesh (2006) in Textbook of Medical Biochemistry, 2nd 
Ed., Elsevier, New Delhi. 
 stream occurs via glucose transporters.  Skeletal muscle absorbs glucose mainly 
via glucose transporter 4 (8, 9).  During exercise these transporters migrate from 
the cytoplasm to the plasma membrane in order to function.  Unlike in resting 
muscle, the movement of these transporters is not a function of the hormone 
insulin.  Rather, the movement is believed to be influenced by Ca2+ (10).  The 
mechanism by which Ca2+ stimulates this movement has not been fully 
elucidated.  Evidence suggests that contraction-related pathways involving 
protein kinase C (PKC) and adenosine monophosphate kinase (AMPK) pathways 
may be used (11, 12).  Since the levels of glucose in the blood are maintained by 
the breakdown of glycogen in the liver, hepatic glycogenolysis may be as 
important for sustaining muscle contraction during activity as skeletal muscle 
glycogenolysis (13). 
 Numerous diseases are associated with abnormalities in different 
enzymes involved in the regulation and utilization of glycogen.  Collectively, 
these diseases are referred to as glycogen storage diseases (GSD) or 
glycogenoses (14).  Such diseases are identifiable in humans via genetic testing 
as well as other mammals such as rats and mice.  The cause of each type of 
GSD is unique, and most are not yet fully understood.  One deficiency that has 
been under investigation for some time is the PhK deficiency observed in I strain 
(I/LnJ) mice (15).  The PhK deficiency found in these mice affects their ability to 
breakdown glycogen in skeletal muscle (16, 17).  PhK activity has been 
measured to be 0.2-0.3% of normal in the limb and back muscles of these mice 
5 
 and 1.5% of normal in the soleus muscle (15, 16, 18).  It has also been 
determined that the α, β, and γ subunits of PhK are absent in the skeletal muscle 
(16, 19).  A mutation in the muscle specific α-subunit of the enzyme (PHKA1) is 
the suggested cause of the deficiency and absence of all three subunits (20, 21). 
 In humans, skeletal muscle PhK deficiencies occur much less frequently 
than hepatic PhK deficiencies.  However, there are well documented examples in 
human patients.  Several patients, who were confirmed to have skeletal muscle 
PhK deficiencies via genetic testing, presented with muscle weakness and rapid 
fatigue upon exercise (22, 23).  Other dominant symptoms included muscle 
cramps or muscle stiffness combined with exercise intolerance (24, 25, 26). 
 Rodent glycogenoses provide animal models for studying the causes of 
such diseases in order to gain insight into the human disease.  The goal of this 
particular research project was to explore the physiological and metabolic 
adaptations that occur as a result of voluntary exercise in the PhK deficient I 
strain mice.   Given the symptoms presented in human patients, it was predicted 
that mice with a similar deficiency would likely endure less voluntary exercise 
likely due to muscle weakness and cramping.  Since it is likely that the I strain 
mice have to utilize sources of energy other than glycogen in order to maintain 
activity, it is expected that the expression levels of several key enzymes involved 
in carbohydrate metabolism will be affected by the deficiency.  
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 CHAPTER 2 
 
MATERIALS AND METHODS 
 
Exercise Study 
 The mice used in this study were wild type C57/Bl6 and PhK-deficient 
I/LnJ mice, also called I strain mice.  Mice were housed in an IACUC approved 
facility with water and food provided ad libitum.  Both adult mice and juvenile 
mice were tested at 12-14 weeks and 6-8 weeks of age, respectively.  Each 
mouse was placed in a separate cage with a standard 6 inch hamster wheel 
equipped with a SigmaTM speedometer (Figure 2.1).  Each speedometer was set 
to a wheel 3672 units (as consistent with the speedometer’s programming) in 
circumference to increase the sensitivity of the sensor.  Upon analysis, the data 
were corrected for the actual circumference of the wheels, approximately 459 
mm.  This circumference is an estimate since all the wheels vary slightly on the 
millimeter scale. 
 The mice were allowed to voluntarily exercise on the hamster wheels for a 
one, two, or five week exercise period.  The speedometers recorded the daily 
time, daily distance, and total distance each mouse ran throughout the exercise 
period.  The data from the computers were collected every 48 to 72 hours until
7 
 8 
A 
C 
B 
Figure 2.1.  Exercise study, equipment and set up. A: C57/Bl6 mouse running on 6 inch hamster 
wheel.  Solid arrow = sensor.  Broken arrow = magnet attached to wheel. B: Mouse housing facility.  C: 
SigmaTM speedometer. 
 
 the completion of the exercise period and used to calculate average daily running 
time and distance, as well as average running speeds.  Between two and ten 
biological replicates were tested for each experimental group according to the 
amount of mice available.    Occasionally, data was unable to be collected for the 
adult mice since they were prone to chew through the speedometer wires.  The 
data for the biological replicates were averaged with outliers, any data point two 
standard deviations or more from the mean, being removed.  Statistical analyses 
were performed in the form of unpaired t-tests to determine significant 
differences between the activity of the wild type and I strain mice as well as any 
increases in activity over time.  At the end of the exercise period each mouse 
was euthanized.  The body mass and heart mass of each mouse was quantified 
to observe anatomical adaptations to the exercise.   
 
Gene Expression Assays 
 Gross muscle samples were taken from the left hind limb of each mouse 
to be used for gene expression studies. Total RNA was isolated from the muscle 
samples using a RNeasy Fibrous Tissue Mini kit [Qiagen].  The RNA was 
converted to cDNA with ABI High Capacity cDNA kit according to the 
manufacturer's protocols [Applied Biosystems].  Expression levels of three genes 
were quantified including: glucose transporter 4 (GLUT4), pyruvate 
dehydrogenase (PDHA1), and phosphofructokinase (PFKM) to observe 
adaptations that may occur in crucial metabolic enzymes (see Chapter 1) as a 
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Figure 2.2. RT-PCR primer standard curves.  A standard curve of pooled cDNA 
assayed at concentrations of 0.1, 0.25, 1.0, 2.5, 10, 25, 100 ng with each primer as 
described in “Materials and Methods.” GUSB = β-glucuronidase; GLUT4 = glucose 
transporter 4; PDHA1 = pyruvate dehydrogenase; PFKM = phosphofructokinase. 
R2 values: GUSB = 0.996, GLUT4 = 0.998, PDHA1 = 0.999, and PFKM = 0.999. 
 response to the PhK deficiency.  The primers used to probe for these genes were 
Taqman Gene Expression Assays purchased from inventory at Applied 
Biosystems.  Each primer was carefully selected to include regions that cross 
exon boundaries.  Expression was quantified using real-time PCR techniques in 
triplicate with a total of three biological replicates each.  In each reaction, 8 ng of 
cDNA was used.  Relative expression was determined from the Ct values which 
represent the cycle at which each sample reached a manually-set threshold of 
amplification for the target gene.  The Ct values were normalized to an 
endogenous control, β-glucuronidase (Gusb), a gene unrelated to the metabolic 
pathways under examination.  A relative standard curve analysis was used to 
correct Ct values, accounting for small variations in primer efficiency.  Standard 
curve samples were made by pooling cDNA from one biological replicate of each 
experimental group and assaying concentrations ranging from 0.1 ng to 100 ng.  
Standard curves for all four primers used can be seen in Figure 2.2.   
11 
 CHAPTER 3 
 
RESULTS 
 
 The cumulative time and distance run by the juvenile mice during the 
exercise period are shown in Figure 3.1.  After two weeks of voluntary exercise, 
wild-type mice ran both significantly more cumulative time and distance than the 
age-matched I strain mice.  Following five weeks of exercise, the I strain mice ran 
116 ± 6 hours and 211 ± 23 km.  Wild-type mice ran an average of 194 ± 3 hours 
and 418 ± 4 km, approximately twice as much as the I strain mice.   
 In the adult mice few significant differences were found in daily activity 
between strains except  the daily amount of time run after two weeks, where wild-
type mice ran 375 ± 15 min/day and the I strain ran 268 ± 64 min/day (Figure 
3.2).  This was not the case in juvenile mice.  After five weeks of exercise, the 
juvenile wild-type mice ran for significantly longer lengths of time on a daily basis 
at 349 ± 15 min/day than the I strain mice at 219 ± 6 min/day.    Juvenile wild-
type mice also ran significantly farther than I strain mice daily, an average of 15 ± 
2 km/day compared to the I strain mice that ran 7 ± 1 km/day. These data 
suggest that the I strain mice were unable to increase their tolerance during the 
exercise period and did not undergo the training affect observed in the wild-type 
12 
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Figure 3.1. Cumulative time and distance. The total amount of time (A) and distance (B) run by juvenile mice is 
shown.  Values are given as averages with error bars representing standard error.  Wild type = dark bars; I strain = 
white bars. n = 2-10. *, p < 0.05 compared to age-matched mice of the opposite strain. 
A B 
 * 
  * 
 * 
 * 
 * 
 * 
* 
 * 
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Figure 3.2. Average daily activity. The average daily activity of adult (A, B) and juvenile (C, D) mice is shown.  
Daily distances in kilometers (A, C) and daily times in minutes (B, D) are given as averages with error bars 
representing standard error. Adult = striped bars; Juvenile = solid bars; Wild type = dark bars; I strain = white 
bars. n = 2-10. *, p < 0.05 compared to age-matched mice of the opposite strain. #, p < 0.05 compared to 1 
week of same strain. 
A B 
C D   * 
 * 
  * 
 * 
* 
 * 
  # 
 mice. 
 These daily activity levels are comparable to those reported by Allen, et al. 
(2001) in an exercise study done of C57/Bl6 mice.  In this study, mice 8-10 
weeks old ran between 3.1 and 16.2 km/day.  The adult wild-type mice in our 
study ran a higher maximum of 18.6 km/day after five weeks, but otherwise all of 
the wild-type mice data fall into this range.  It was also reported that the mice in 
Allen, et al. (2001) ran between 2.4 and 7.1 hours per day which is equivalent to 
144-426 min/day.  The averages found in our study for the juvenile (6-8 weeks) 
and adult mice (10-12 weeks) fall within this range (Figure 3.2). 
 Interestingly, both juvenile and adult mice of each strain ran approximately 
the same speed as shown in Figure 3.3.  After five weeks, wild-type and I strain 
juvenile mice were running 43 ± 4 m/min and 32 ± 3 m/min respectively, whereas 
adult wild-type and I strain mice ran 48 ± 5 m/min and 39 ± 5 m/min after five 
weeks of acclimation to the exercise.  After statistical analysis by t-test, these 
speeds were determined to be not significantly different.  Therefore, I strain mice 
were on average able to run as fast as healthy wild-type mice.  It is notable that 
these averages are higher on average than those reported elsewhere for 
C57/Bl6.   The range of speeds for the juvenile mice in the present study 
measured 22.4 m/min-63.2 m/min compared to an average of 26.4 m/min and 
maximum of 44.8 m/min reported by Allen, et al. (2001).  This is an expected 
discrepancy given that the maximum km/day data is also higher in the present 
study, but the min/day data between the two studies are consistent. 
15 
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Figure 3.3. Average running speed. The average speeds run by adult (A) and juvenile (B) mice are shown.  
Values are given as averages with error bars representing standard error.  Wild type = dark bars; I strain = 
white bars. n = 2-10. *, p < 0.05 compared to age-matched mice of the opposite strain. #, p < 0.05 compared to 
1 week of same strain. 
A B  # 
  Heart mass/body mass (mg/g) ratios were determined (Table 1) in order to 
assess physiological hypertrophy that may have resulted from the exercise.  
Compared to the unexercised controls, no significant differences were found in 
the wild-type or I strain exercised mice, indicating a lack of cardiac hypertrophy.  
Furthermore, no significant increases in the heart mass/body mass ratios were 
observed among any of the experimental groups as the length of the exercise 
period increased. 
 The observation of physiological adaptations was followed by a study of 
the metabolic adaptations in these mice by gene expression assays (Figure 3.4).  
The relative expressions of mRNA for glucose transporter type 4 (GLUT4), 
phosphofructokinase (PFKM), and pyruvate dehydrogenase (PDHA1) are shown 
for the juvenile wild-type and I strain mice only.  The singularly significant 
difference determined among the expressions levels was that of PDHA1 in wild-
type five-week mice versus the unexercised wild-type control.  Comparing the I 
strain mice to wild-type, there were no significant differences between the 
expression levels of any of the three genes tested.  It is possible that the lack of 
significance is due to the high variability among biological replicates, which would 
also suggest that the set of genes observed was not affected in a consistent 
manner due to the PhK deficiency. 
17 
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  Wild Type  I strain 
  
One 
Week 
Two 
Weeks 
Five 
Weeks 
Unexercised 
Control 
 
 
One 
Week 
Two 
Weeks 
Five 
Weeks 
Unexercised 
Control 
Heart Mass (mg) 90.0 ± 5.8 
106.0 ± 
6.8 
122.6 ± 
6.0 116.7 ± 14.5  
97.7 ± 
1.9  105.6* 
116.4 ± 
3.8 125.0 ± 7.7 
Body Mass (g) 16.5 ± 0.6 
18.1 ± 
.8 
18.9 ± 
1.1 19.0 ± 1.8  
15.9 ± 
0.6 18.0* 
20.2 ± 
0.9 22.0 ± 1.3 Juvenile 
HM/BM 5.4 ± 0.3 5.9 ± 0.5 6.5 ± 0.1 6.1 ± 0.2  
6.2 ± 
0.3 5.9* 5.8 ± 0.2 5.7 ± 0.03 
Heart Mass (mg) 146.9 ± 8.5 
133.7 ± 
8.7 
138.5 ± 
17.0 131.6 ± 5.2  120.6* 
124.4 ± 
6.4 
132.5 ± 
12.4 126.8* 
Body Mass (g) 23.7 ± 0.7 
23.2 ± 
0.8 
23.4 ± 
1.3 23.5 ± 1.6  18.8* 
20.1 ± 
0.5 
21.3 ± 
1.8 20.7* Adult 
HM/BM 6.2 ± 0.6 5.7 ± 0.2 5.9 ± 0.6 5.7 ± 0.4  6.4* 6.2 ± 0.3 6.2 ± 0.1 6.1* 
Table 1. Heart mass/body mass ratios. Values are given as averages ± standard error. n = 2-10.  *Data 
points are the average of two mice. 
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Figure 3.4. Gene expression. The relative expressions of GLUT4 (A), PFKM (B), and PDHA1 (C) in juvenile 
skeletal muscle are shown. Values represent the average of three biological replicates with error bars 
representing standard error.  Wild type = dark bars; I strain = white bars; UEC = unexercised control. Relative 
expression is given as units of cDNA calculated using a relative standard curve method (see “Materials and 
Methods”). #, p < 0.05 compared to unexercised control.  
 
A 
B 
C 
  # 
 CHAPTER 4 
 
DISCUSSION 
 
 The exercise study demonstrated that of all the exercise groups, adult 
wild-type mice were most susceptible to training effects.  There was a statistically 
significant increase in the average speed they ran after one week compared to 
five weeks, 30 ± 2 m/min versus 48 ± 5 m/min respectively.  Furthermore, they 
increased from an average of 11 ± 2 km/day after one week of exercise to 19 ± 2 
km/day after five weeks of exercise, illustrating a significant difference (p < 0.05).  
Although similar increases were seen in the juvenile wild-type mice and some of 
the I strain mice, none were statistically significant, suggesting the adult wild-type 
mice underwent the most physiological conditioning with the voluntary exercise.  
 The physiological conditioning observed in the exercise data was not 
reflected in the heart mass/body mass data.  In a study by Allen et al. (2001), it 
was determined that voluntary exercise via wheel-exposure was enough to 
increase cardiac mass in wild-type C57/Bl6 mice.  Such an increase was not 
observed in the present study comparing exercised mice to their unexercised 
age-matched controls.  After five weeks of exercise, the average heart to body 
mass ratio did increase slightly in all experimental groups, but not with any
20 
 statistical significance.  It is possible that given a larger sample size, such as that 
used in the study by Allen et al. (2001) of twelve control mice, the data might 
reflect these physiological effects more accurately.  
 Overall the differences in the activity levels of wild-type and the I strain 
mice are not hard to distinguish, but become statistically significant only after 
several weeks of acclimation to exercise.  The most apparent difference is found 
in the total time and distance run by the two mice strains, where after five weeks 
of exercise the I strain mice ran an average of 211 ± 23 km and wild-type mice 
ran 418 ± 4 km, approximately twice the distance.  Although the daily distances 
and time periods run by the two strains were not significantly different initially, the 
difference in their activity levels became apparent over the five-week period.  
This difference in their amount of voluntary activity is surprising when contrasted 
to the observation made by Lyon et al. (1963) that the I strain mice were capable 
of swimming up to twice as long as wild-type C57/Bl6 mice.  One hypothesis may 
be that the mechanism of metabolism used by the I strain mice as an alternative 
to glycogen metabolism can sustain increased endurance under forced 
conditions; however, under voluntary conditions the I strain, while capable of 
much activity, opt to exercise less than normal mice.  Further studies on the 
methods of metabolism utilized by the I strain mice would have to be conducted. 
 In Pederson et al. (2005), it was suggested that liver glycogen stores may 
be quantitatively more important in rodent exercise than skeletal muscle 
glycogen.  If we assume that liver glycogenolysis is more important than muscle 
21 
 glycogenolysis, the results of the exercise study at minimum demonstrate that 
muscle glycogenolysis is not inconsequential.  It is also important to note that the 
study by Pederson et al. (2005) was conducted under forced conditions and the 
mice were exercised to exhaustion.  Under these conditions, it is likely that the 
abundance of muscle glycogen is insufficient to meet the demand, so hepatic 
glycogen stores must be used. 
 Whether or not the I-strain mice would function as a viable mouse model 
for human glycogenoses is still in question.  According to Pederson et al. (2005) 
hepatic glycogen may be more important for exercise than skeletal muscle 
glycogen, which is not necessarily true of humans.  The prevailing view is that 
skeletal muscle glycogen is indeed a determining factor in human endurance (29, 
30).  However, liver glycogen stores are known to deplete under strenuous 
exercise conditions by 50% or more after only one hour (3).   
 It is also difficult to determine if the clinical symptoms (muscle cramps, 
weakness, and exhaustion) that are present in human skeletal muscle PhK 
deficiencies affect the I strain mice and how much stress is needed to induce 
them.  Since it was only after five weeks of voluntary exercise that the I-strain 
mice showed significant decreases in their activity levels compared to wild-type, 
one possibility is that the level of intensity of exercise was not significant enough 
to affect their performance via cramps or exhaustion.  As mentioned above, it has 
also been observed that under forced exercise conditions the I strain mice 
performed better than wild-type mice (28).  However, that does not necessarily 
22 
 mean that the I strain mice did not experience cramps or muscle pain.  In the 
case of Lyon, et al. (1963) the mice were forced to swim to exhaustion, meaning 
that even if the activity became painful for the mice they may have endured it for 
the sake of survival. 
 The present study demonstrates that I strain mice, while capable of 
voluntary exercise in equitable amounts, show decreased basal activity levels 
compared to a healthy mouse strain.  Initial gene studies did not reveal a 
significant difference in the expression of key glycolytic and metabolic enzymes 
between wild-type and I strain mice.  Hopefully, further gene studies will be able 
to identify an alternative energy source or metabolic mechanism that allows the I 
strain mice to maintain activity for several hours per day without the use of 
skeletal muscle glycogen.  Insight into the intricacies of human glycogenoses will 
expectedly be gleaned from further study and a deeper understanding of these 
mice.  
23 
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